This company develops a device for antimicrobial susceptibility testing, enabling rapid measurement and observation of cell growth and response in liquid samples. Their technology assists healthcare professionals by providing high-resolution measurement of mass in fluid and detecting positive growth, facilitating faster and more accurate diagnoses.
Funding
$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Conventional antimicrobial susceptibility testing (AST) methods can be slow, delaying appropriate antibiotic therapy and potentially leading to poorer patient outcomes, increased costs, and the spread of antimicrobial resistance. Current rapid AST methods may lack the accuracy needed to confidently guide treatment decisions, especially with the rise of bacteria exhibiting delayed growth.
Solution
Affinity Biosensors' LifeScale AST system addresses the need for rapid and accurate antimicrobial susceptibility testing. The LifeScale system utilizes a patented technology that combines population profiling with advanced AI to provide phenotypic AST results in approximately 4.5 hours. The system employs a microfluidic sensor to measure the masses of individual bacteria, generating a detailed population profile for each culture. This data is then analyzed using the AI-Predictor™ to determine the correct minimum inhibitory concentration (MIC), even in cases of delayed growth, enabling clinicians to make informed decisions and optimize antibiotic use.
Target Audience
The primary target audience includes clinical microbiology laboratories in hospitals and healthcare institutions that require rapid and accurate AST results for Gram-negative bacteria in positive blood cultures to improve patient care and support antimicrobial stewardship programs.
Features
- Rapid AST results in approximately 4.5 hours, enabling faster treatment decisions.
- Population profiling technology that measures the masses of thousands of individual bacteria.
- Microfluidic sensor for precise measurement of microbe replication and culture growth.
- AI-Predictor™ that analyzes population profiles to determine accurate MICs, even for delayed-growth phenotypes.
- Seamless integration into existing laboratory workflows, utilizing the same well plates and antimicrobials as standard AST methods.
- Benchtop form factor with automated inoculation, incubation, reading, and reporting.
- Parallel processing of up to 4 ASTs to support the sample volumes of most hospitals.
- Compact AST kits that can be stored at room temperature for up to one year.